BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17956704)

  • 21. Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?
    Koç H; Gürman G; Arslan O; Ozcan M; Dilek I; Akan H; Ilhan O; Konuk N; Beksaç M; Uysal A
    J Chemother; 1997 Oct; 9(5):371-6. PubMed ID: 9373793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia--a single-center experience.
    Wang H; Wang Z; Zheng X; Ding L; Zhu L; Yan H; Guo Z
    Cytotherapy; 2013 Sep; 15(9):1118-25. PubMed ID: 23806238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia.
    Zhao XS; Chen Y; Zhao XY; Liu DH; Xu LP; Wang Y; Han W; Chen YH; Chen H; Zhang XH; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(6):844-51. PubMed ID: 23992032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
    Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
    Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor.
    Bensinger WI; Clift RA; Anasetti C; Appelbaum FA; Demirer T; Rowley S; Sandmaier BM; Torok-Storb B; Storb R; Buckner CD
    Stem Cells; 1996 Jan; 14(1):90-105. PubMed ID: 8820955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
    Ozcan M; Ustün C; Akçağlayan E; Akan H; Arslan O; Ilhan O; Beksaç M; Gürman G; Demirer T; Arat M; Celebi H; Konuk N; Uysal A; Koç H
    Bone Marrow Transplant; 2001 Mar; 27(5):499-505. PubMed ID: 11313683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte-mobilized bone marrow.
    Arcese W; De Angelis G; Cerretti R
    Curr Opin Hematol; 2012 Nov; 19(6):448-53. PubMed ID: 22954729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic transplantation for hematological malignancies using rho G-CSF mobilized blood stem cells.
    Azevedo WM; Aranha FJ; Gouvea JV; Vigorito AC; Marques JF; Eid KA; Azevedo AM; Barbosa KB; Souza CA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S54-5. PubMed ID: 8722337
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
    Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
    Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor.
    Gyger M; Stuart RK; Perreault C
    Bone Marrow Transplant; 2000 Jul; 26(1):1-16. PubMed ID: 10918400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The efficacy and safety of recombinant human granulocyte colony stimulating factor primed donor peripheral cell harvest in treatment of poor graft function after allogeneic stem cell transplantation].
    Sun YQ; Liu DH; Xu LP; Zhang XH; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):730-3. PubMed ID: 24314160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of granulocyte colony stimulating factor on myeloid-derived suppressor cells in the bone marrow and peripheral blood: a preliminary study].
    Ling YW; Liu QF; Liu C; Wu XL; Chen YK; Fan ZP; Xuan L; Zhang Y; Jiang QL; Zhao J; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1190-2. PubMed ID: 21764692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review.
    Chang YJ; Huang XJ
    Clin Transplant; 2011; 25(1):13-23. PubMed ID: 20626760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Allogeneic peripheral blood stem cell transplantation].
    Harada M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1877-85. PubMed ID: 8978790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications.
    Ringdén OT; Le Blanc K; Remberger M
    Exp Hematol; 2005 May; 33(5):505-12. PubMed ID: 15850828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.